QPQ-19961-77452
2 vaccinations
4 coded responses
16 check-ins
4 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 36-40
- ZIP prefix
- 774 / TX
- Registered
- 2021-01-11
- Relationship
- Self
- Race
- N/A
- Ethnicity
- N/A
Timeline
-
2021-01-11
Registered in v-safe
-
2021-01-11
Dose 1 — Moderna
- 2021-01-11
- 2021-01-12
- 2021-01-13
- 2021-01-15
- 2021-01-16
- 2021-01-18
- 2021-01-25
-
2021-02-01
Survey response — day 21, dose 1MedDRA: Rash — Feeling: GoodFree text: Rash on my abdomen.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-02-08
Dose 2 — Moderna
- 2021-02-15
- 2021-02-22
- 2021-03-08
- 2021-03-15
- 2021-03-22
-
2021-05-10
Survey response — 3 months, dose 2MedDRA: Rash — Feeling: GoodFree text: Abdominal rashMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-08-09
Survey response — 6 months, dose 2MedDRA: Fatigue, Sensitive skin — Feeling: Good · Be unable to do your normal daily activitiesFree text: Extreme fatigue regularly. Increased skin sensitivity.MedDRA releases: 2021-09,2024-11 · check-in free text available
-
2022-02-10
Survey response — 12 months, dose 2MedDRA: Abortion spontaneous, Medical counselling, Office visit — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professionalFree text: Symptoms: Miscarriage · Healthcare visit (other): Did not make it to emergency room, care at home then to obgynMedDRA releases: 2024-11 · check-in free text available
-
2022-02-10
Report sent to call center — 12 months, dose 2Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr1 call case(s)
- 2022-03-04
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-11 | Moderna | |
| 2 | 2021-02-08 | Moderna |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2022-02-10 | Unsuccessful |
Free text
Release 3 — day 21, dose 1
Symptoms: Rash on my abdomen.
Release 8 — 3 months, dose 2
Symptoms: Abdominal rash
Release 9 — 6 months, dose 2
Symptoms: Extreme fatigue regularly. Increased skin sensitivity.
Release 11 — 12 months, dose 2
Symptoms: Miscarriage
Healthcare visit (other): Did not make it to emergency room, care at home then to obgyn
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | Medical counselling | · | · | ✓ |
| HCVO | Office visit | · | · | ✓ |
| SD | Abortion spontaneous | · | · | ✓ |
| SD | Fatigue | ✓ | · | ✓ |
| SD | Rash | ✓ | ✓ | ✓ |
| SD | Sensitive skin | ✓ | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release